Last $7.86 USD
Change Today -0.64 / -7.53%
Volume 4.4K
MYOS On Other Exchanges
Symbol
Exchange
NASDAQ CM
As of 5:10 PM 11/28/14 All times are local (Market data is delayed by at least 15 minutes).

myos corp (MYOS) Snapshot

Open
$8.98
Previous Close
$8.50
Day High
$9.00
Day Low
$7.86
52 Week High
07/22/14 - $16.85
52 Week Low
01/24/14 - $6.00
Market Cap
22.9M
Average Volume 10 Days
8.1K
EPS TTM
$-1.89
Shares Outstanding
2.9M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for MYOS CORP (MYOS)

Related News

No related news articles were found.

myos corp (MYOS) Related Businessweek News

No Related Businessweek News Found

myos corp (MYOS) Details

MYOS Corporation, a development-stage biotherapeutics and nutritional products company, focuses on the discovery, development, and commercialization of nutritional supplements, functional foods, therapeutic products, and other technologies for maintaining or improving the health and performance of muscle tissue. It develops MYO-T12, a dietary supplement product for optimizing biological activity. The company was formerly known as Atlas Therapeutics Corporation and changed its name to MYOS Corporation in May 2012. MYOS Corporation was founded in 2007 and is based in Cedar Knolls, New Jersey.

4 Employees
Last Reported Date: 05/15/14
Founded in 2007

myos corp (MYOS) Top Compensated Officers

President and Chief Operating Officer
Total Annual Compensation: $299.0K
Vice President and Corporate Controller
Total Annual Compensation: --
Compensation as of Fiscal Year 2013.

myos corp (MYOS) Key Developments

MYOS Corp. Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2014

MYOS Corp. reported unaudited consolidated earnings results for the third quarter and nine months ended September 30, 2014. For the quarter, the company's net sales were approximately $107,000 compared to $918,000 a year ago. Loss from operations was $2,177,000 compared to $782,000 a year ago. Net loss and comprehensive income was $2,177,000 compared to $781,000 a year ago. Basic and diluted net loss per share attributable to common stockholders was $0.75 compared to $0.35 a year ago. Non-GAAP, net loss was $1,625,000 compared to $454,000 for a year ago. Non-GAAP basic and diluted net loss per share was $0.56 compared to $0.20 a year ago. For the nine months, the company's net sales were approximately $3,332,000 compared to $1,910,000 a year ago. Loss from operations was $3,601,000 compared to $2,858,000 a year ago. Net loss and comprehensive income was $3,599,000 compared to $2,854,000 a year ago. Basic and diluted net loss per share attributable to common stockholders was $1.28 compared to $1.29 a year ago. Non-GAAP, net loss was $2,267,000 compared to $1,789,000 for a year ago. Non-GAAP basic and diluted net loss per share was $0.81 compared to $0.81 a year ago.

MYOS Corporation to Report Q3, 2014 Results on Nov 14, 2014

MYOS Corporation announced that they will report Q3, 2014 results Pre-Market on Nov 14, 2014

MYOS Corporation, Q3 2014 Earnings Call, Nov 14, 2014

MYOS Corporation, Q3 2014 Earnings Call, Nov 14, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MYOS:US $7.86 USD -0.64

MYOS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for MYOS.
View Industry Companies
 

Industry Analysis

MYOS

Industry Average

Valuation MYOS Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 5.2x
Price/Book 4.4x
Price/Cash Flow NM Not Meaningful
TEV/Sales 5.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MYOS CORP, please visit www.myoscorp.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.